AFR: STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: STADA Arzneimittel AG / Preliminary announcement on the disclosure of financial statements STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 23.02.2023 / 14:15 CET/CEST Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. STADA Arzneimittel AG hereby announces that the following financial reports shall be disclosed: Report Type: Annual financial report Language: German Date of disclosure: March 06, 2023 Address: https://www.stada.com/de/gj2022-jahresabschluss.pdf Language: English Date of disclosure: March 06, 2023 Address: https://www.stada.com/fy2022-financial-statements.pdf 23.02.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Internet:	www.stada.de

End of News	EQS News Service

1567295  23.02.2023 CET/CEST